Literature DB >> 11495677

Secretion of the trefoil factor TFF3 from the isolated vascularly perfused rat colon.

F Moro1, F Levenez, S Durual, P Plaisancié, L Thim, A S Giraud, J C Cuber.   

Abstract

The trefoil factor TFF3 is a peptide predominantly produced by mucus-secreting cells in the small and large intestines. It has been implicated in intestinal protection and repair. The mechanisms that govern TFF3 secretion are poorly understood. The aim of this study was, therefore, to evaluate the influence of neurotransmitters, hormonal peptides and mediators of inflammation on the release of TFF3. For this purpose, an isolated vascularly perfused rat colon preparation was used. After a bolus administration of 1 ml isotonic saline into the lumen, TFF3 secretion was induced by a 30-min intra-arterial infusion of the compounds to be tested. TFF3 was evaluated in the luminal effluent using a newly developed radioimmunoassay. TFF3 was barely detected in crude luminal samples. In contrast, dithiothreitol (DTT) treatment of the effluent revealed TFF3 immunoreactivity, which amounted to about 0.3 pmol min(-1) cm(-1) in the basal state. Gel chromatography of DTT-treated luminal samples revealed a single peak that co-eluted with the monomeric form of TFF3. TFF3 was not detected in the portal effluent. Bethanechol (10(-6)-10(-4) M), vasoactive intestinal peptide (VIP, 10(-8)-10(-7) M) or bombesin (10(-8)-10(-7) M) induced a dose-dependent release of TFF3. In contrast, substance P evoked a modest release of TFF3, whereas calcitonin gene-related peptide (CGRP), somatostatin, neurotensin or peptide YY (PYY) did not modify TFF3 secretion. The degranulator compound bromolasalocid, 16,16-dimethyl PGE2 (dmPGE2) or interleukin-1-beta (IL-1-beta) also evoked a marked release of TFF3. In conclusion, TFF3 in the colonic effluent is present in a complex. This association presumably involves a disulfide bond. Additionally, the present results suggest a role for enteric nervous system and resident immune cells in mediation of colonic TFF3 secretion.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11495677     DOI: 10.1016/s0167-0115(01)00257-9

Source DB:  PubMed          Journal:  Regul Pept        ISSN: 0167-0115


  7 in total

Review 1.  Neurons and Glia in the Enteric Nervous System and Epithelial Barrier Function.

Authors:  Nathalie Vergnolle; Carla Cirillo
Journal:  Physiology (Bethesda)       Date:  2018-07-01

Review 2.  Role of enteric neurotransmission in host defense and protection of the gastrointestinal tract.

Authors:  Keith A Sharkey; Tor C Savidge
Journal:  Auton Neurosci       Date:  2013-12-22       Impact factor: 3.145

3.  TFF3 modulates NF-{kappa}B and a novel negative regulatory molecule of NF-{kappa}B in intestinal epithelial cells via a mechanism distinct from TNF-{alpha}.

Authors:  Ya-Qin Zhu; Xiao-Di Tan
Journal:  Am J Physiol Cell Physiol       Date:  2005-07-13       Impact factor: 4.249

4.  Epithelial cell types and their proposed roles in maintaining the mucosal barrier in human chagasic-megacolonic mucosa.

Authors:  Christian Koch; Alexandre B M da Silveira; Enio C de Oliveira; Karl Quint; Winfried Neuhuber; Axel Brehmer; Samir Jabari
Journal:  Histochem Cell Biol       Date:  2017-03-29       Impact factor: 4.304

5.  The intestinal trefoil factor (Tff3), also expressed in the inner ear, interacts with peptides contributing to apoptosis.

Authors:  M Lubka; A A Shah; N Blin; M Baus-Loncar
Journal:  J Appl Genet       Date:  2009       Impact factor: 3.240

6.  Effects of topical treatment of sodium butyrate and 5-aminosalicylic acid on expression of trefoil factor 3, interleukin 1beta, and nuclear factor kappaB in trinitrobenzene sulphonic acid induced colitis in rats.

Authors:  M Song; B Xia; J Li
Journal:  Postgrad Med J       Date:  2006-02       Impact factor: 2.401

7.  Vasoactive intestinal polypeptide promotes intestinal barrier homeostasis and protection against colitis in mice.

Authors:  Xiujuan Wu; Victoria S Conlin; Vijay Morampudi; Natasha R Ryz; Yasmin Nasser; Ganive Bhinder; Kirk S Bergstrom; Hong B Yu; Chris C M Waterhouse; Allison M J Buchan; Oana E Popescu; William T Gibson; James A Waschek; Bruce A Vallance; Kevan Jacobson
Journal:  PLoS One       Date:  2015-05-01       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.